CN110384744A - A kind of composition and preparation method treated scytitis and promote wound healing - Google Patents
A kind of composition and preparation method treated scytitis and promote wound healing Download PDFInfo
- Publication number
- CN110384744A CN110384744A CN201910786021.3A CN201910786021A CN110384744A CN 110384744 A CN110384744 A CN 110384744A CN 201910786021 A CN201910786021 A CN 201910786021A CN 110384744 A CN110384744 A CN 110384744A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- scytitis
- wound healing
- urea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to medical composition technical fields, a kind of composition and preparation method treated scytitis and promote wound healing is disclosed, the composition includes the pure material component of following parts by weight: 5500-6500 parts of terramycin, 30-45 parts of vitamin B2,20-40 parts of berberine, 800-1200 parts of azithromycin, 2500-3500 parts of Fluocinonide, 1000-1400 parts of urea, 60-100 parts of vitamin E and 120-170 parts of erythromycin；Preparation method is comprising steps of preparing powder materials, preparing drug powder material, prepare sticky material and prepare externally used paste.The present invention has preferable therapeutic effect for dermatitis, epifolliculitis, furuncle, impetigo, psoriasis, acne, eczema, psoriasis and tinea pedis.
Description
Technical field
The invention belongs to medical composition technical fields, and in particular to a kind of group treated scytitis and promote wound healing
Close object and preparation method.
Background technique
Skin disease (dermatosis) is the general name occurred in skin and skin accessory organ's disease.Skin is human body maximum
Organ, dermopathic type is not only various, and the disease that a variety of internal organ occur can also have performance on the skin.Cause skin disease
The reason of very much, such as skin disease caused by infective agent, such as leprosy, scabies, nosomycosis, bacterial skin infections usually have one
Fixed infectiousness not only influences health, and raises fear and social discrimination, but with the improvement of people ' s living standards
And scientific and technological progress, the infectious diseases such as leprosy have been obviously controlled in the whole world.Other cause it is dermopathic it is inside and outside because
Element, such as mechanicalness, it is physical, chemically, biological, incretion, immunity, be increasingly valued by people at present.
In skin disease it is most common to pathogenic factor be infection disease and allergic dermatitis.Specifically it is summarized as following a few classes:
1. chemical factors: the factors such as pressure and friction, local temperature variation be too fast, radiation, illumination, heat radiation, chemical reagent can draw
Play skin disease.Some factors can aggravate skin disease.Such as excessively scratching secondary infection；Hot water scalds, soap is washed, inappropriate medication
Aggravate eczema lesion；Exposure can aggravate photosensitive diseases.2. biological factor: insect bites, contact certain plants, helminth with it is micro-
Biological infection is common causative factors, the various virus dermatopathies as caused by virus infection.3. food and other diseases: having
A little food such as shrimps etc. easily cause anaphylactia.Viscera, local infection, blood and disturbances of lymph circulation etc. can cause phase
Skin disease is closed, if diabetic is susceptible to suffer from pruritus, local infection causes dermatitis infectiosa eczematoides, and dyshaemia can cause purple
Dark purple, elephantiasis etc..
Whether can quickly get well for patient, anti-inflammatory process plays conclusive effect.And common wound is controlled
Treatment method be first wound dressing is good, anti-inflammatory as infusion take medicine by way of allow the inflammation of wound to eliminate, and Causative virus or
Often there is certain drug resistance to common antibiotic in bacterium, and using stronger antibiotic to exist becomes virus or bacterium
The risk of different generation drug resistance, causes traumatic wounds indolence, is easy recurrence.
Currently, yet there are no the preferable product of effect for the healing recovery of the traumatic symptom of scytitis and skin.
Summary of the invention
In order to solve the above problems existing in the present technology, it is an object of that present invention to provide a kind of scytitis for the treatment of to promote
The composition and preparation method of wound healing.
The technical scheme adopted by the invention is as follows:
A kind of composition treated scytitis and promote wound healing, the pure material component including following parts by weight: soil
5500-6500 parts of mycin, 30-45 parts of vitamin B2,20-40 parts of berberine, 800-1200 parts of azithromycin, Fluocinonide
2500-3500 parts, 1000-1400 parts of urea, 60-100 parts of vitamin E and 120-170 parts of erythromycin.
Further, a kind of composition treated scytitis and promote wound healing, including following parts by weight
Pure material component: 5500-6500 parts of terramycin, 30-45 parts of vitamin B2,20-40 parts of berberine, azithromycin 800-
1200 parts, 2500-3500 parts of Fluocinonide, 1000-1400 parts of urea, 60-100 parts of vitamin E, 120-170 parts of erythromycin
With 40-80 parts of Ofloxacin.
Further, a kind of composition treated scytitis and promote wound healing, including following parts by weight
Pure material component: 5500-6500 parts of terramycin, 30-45 parts of vitamin B2,20-40 parts of berberine, azithromycin 800-
1200 parts, 2500-3500 parts of Fluocinonide, 1000-1400 parts of urea, 60-100 parts of vitamin E, erythromycin 120-170
Part, 40-80 parts of Ofloxacin, 40-80 parts of kuh-seng, 40-80 parts of frutus cnidii, 30-50 parts of bodinier velvetplant root, 50-70 parts of plain rice tree, white wolf
Malicious 30-50 parts and nauclea officinalis 50-70 parts.
Further, a kind of composition treated scytitis and promote wound healing, including following parts by weight
Pure material component: 5600-6200 parts of terramycin, 35-40 parts of vitamin B2,25-35 parts of berberine, azithromycin 900-
1100 parts, 2800-3200 parts of Fluocinonide, 50-70 parts of Ofloxacin, 1200-1300 parts of urea, 70-90 parts of vitamin E,
45-65 parts of kuh-seng, 45-75 parts of frutus cnidii, 35-45 parts of bodinier velvetplant root, 55-65 parts of plain rice tree, 35-45 parts of euphorbiae fischerianae, nauclea officinalis 55-65
Part and erythromycin 140-160 parts.
Further, a kind of composition treated scytitis and promote wound healing, including following parts by weight
Pure material component: 6200 parts of terramycin, 40 parts of vitamin B2,35 parts of berberine, 1100 parts of azithromycin, Fluocinonide
3000 parts, it is 55 parts of Ofloxacin, 1250 parts of urea, 70 parts of vitamin E, 60 parts of kuh-seng, 50 parts of frutus cnidii, 35 parts of bodinier velvetplant root, white
65 parts of meal tree, 35 parts of euphorbiae fischerianae, 55 parts of nauclea officinalis and 150 parts of erythromycin.
Further, a kind of composition treated scytitis and promote wound healing, including following parts by weight
Pure material component: 6000 parts of terramycin, 35 parts of vitamin B2,30 parts of berberine, 1000 parts of azithromycin, Fluocinonide
3000 parts, it is 60 parts of Ofloxacin, 1200 parts of urea, 80 parts of vitamin E, 60 parts of kuh-seng, 60 parts of frutus cnidii, 40 parts of bodinier velvetplant root, white
60 parts of meal tree, 40 parts of euphorbiae fischerianae, 60 parts of nauclea officinalis and 150 parts of erythromycin.
Further, a kind of composition treated scytitis and promote wound healing, including following parts by weight
Pure material component: 6400 parts of terramycin, 42 parts of vitamin B2,35 parts of berberine, 1100 parts of azithromycin, Fluocinonide
3100 parts, it is 60 parts of Ofloxacin, 1200 parts of urea, 80 parts of vitamin E, 60 parts of kuh-seng, 60 parts of frutus cnidii, 45 parts of bodinier velvetplant root, white
65 parts of meal tree, 45 parts of euphorbiae fischerianae, 65 parts of nauclea officinalis and 150 parts of erythromycin.
Further, a kind of composition treated scytitis and promote wound healing, including following parts by weight
Pure material component: 6200 parts of terramycin, 40 parts of vitamin B2,40 parts of berberine, 1000 parts of azithromycin, Fluocinonide
3200 parts, it is 60 parts of Ofloxacin, 1200 parts of urea, 90 parts of vitamin E, 60 parts of kuh-seng, 70 parts of frutus cnidii, 45 parts of bodinier velvetplant root, white
60 parts of meal tree, 40 parts of euphorbiae fischerianae, 60 parts of nauclea officinalis and 160 parts of erythromycin.
Further, the dosage form of the composition is externally used paste.
A kind of preparation method treated scytitis and promote the composition of wound healing, comprising steps of
First terramycin powder, berberine powder, vitamin B2 powder are stirred evenly, are then uniformly sprinkled into Zitromax
Element obtains powder materials；
Lightyellow Sophora Root, Common Cnidium Fruit, bodinier velvetplant root's powder, plain rice tree powder, euphorbiae fischerianae powder and nauclea officinalis powder are mixed,
Obtain drug powder material；
Fluonex, ofloxacin gel, powder materials and drug powder material are stirred evenly, sticky material is obtained；
Urea and vitamin E cream, erythromycin ointment and sticky material are mixed, externally used paste is obtained；
Effective component in the Fluonex, ofloxacin gel, urea and vitamin E cream and erythromycin ointment contains
It measures consistent to the content of the corresponding ingredient in the composition.
The invention has the benefit that a kind of composition and preparation treated scytitis and promote wound healing of the invention
Method plays the role of inhibiting lesion growth by Fluocinonide；Terramycin plays bacteriostasis；Berberine further functions as
Bacterial growth is inhibited to promote pharmacological；Vitamin B2 plays the role of regaining the function, myogenic and can play antibacterial anti-inflammatory；Urea,
Vitamin E, which plays cutin-softening skin, makes skin emolliency, maintains the function of muscle, neural normal development；To which the present invention passes through
Inhibit lesion growth, restraining and sterilizing bacteria, antalgesic-antipruritic, anti-inflammatory, softening skin regain the function myogenic, maintain muscle, nerve normally to send out
The function of educating.To which composition through the invention, which is realized, plays treatment and promotion to the healing of scytitis and wound
Effect；For other more serious dermatitis, epifolliculitis, furuncle, impetigo, psoriasis, acne, eczema, psoriasis and tinea pedis
Diseases are waited, play the role of sterilizing treatment tinea by the way that Ofloxacin is added in composition of the invention；Kuh-seng, frutus cnidii, pesticide-germicide
It is antipruritic；Bodinier velvetplant root, plain rice tree treat dermatitis, eczema；Euphorbiae fischerianae, nauclea officinalis play treatment cutaneous tuberculosis, neurodermatitis, ox-hide
Tinea；Nauclea officinalis plays the role for the treatment of dermatitis and eczema, the ringworm of the foot；Erythromycin plays the above-mentioned all drugs of linking and plays a role, to rise
To the inhibition and therapeutic effect to diseases such as dermatitis, epifolliculitis, furuncle, impetigo, psoriasis, acne, eczema, psoriasis and tinea pedis
While, realize the inhibition lesion growth to skin, restraining and sterilizing bacteria, antalgesic-antipruritic, anti-inflammatory, softening skin regain the function life
Flesh, maintain muscle, neural normal development function purpose.
Specific embodiment
Pure material component in this specification refers to pure substance of the purity close to 100%.
Further explaination is done to the present invention combined with specific embodiments below.
One, drug forms
A kind of composition treated scytitis and promote wound healing, the pure material component including following parts by weight: soil
5500-6500 parts of mycin, 30-45 parts of vitamin B2,20-40 parts of berberine, 800-1200 parts of azithromycin, Fluocinonide
2500-3500 parts, 1000-1400 parts of urea, 60-100 parts of vitamin E and 120-170 parts of erythromycin.
A kind of composition treated scytitis and promote wound healing, the pure material component including following parts by weight: soil
5500-6500 parts of mycin, 30-45 parts of vitamin B2,20-40 parts of berberine, 800-1200 parts of azithromycin, Fluocinonide
2500-3500 parts, 1000-1400 parts of urea, 60-100 parts of vitamin E, 120-170 parts of erythromycin and Ofloxacin 40-80
Part.
Two, application method
Externally used paste is made in the composition to use.
Or it is made with the following method: a kind of preparation method treated scytitis and promote the composition of wound healing, packet
Include step:
First terramycin powder, berberine powder, vitamin B2 powder are stirred evenly, are then uniformly sprinkled into Zitromax
Element obtains powder materials；
Lightyellow Sophora Root, Common Cnidium Fruit, bodinier velvetplant root's powder, plain rice tree powder, euphorbiae fischerianae powder and nauclea officinalis powder are mixed,
Obtain drug powder material；
Fluonex, ofloxacin gel, powder materials and drug powder material are stirred evenly, sticky material is obtained；
Urea and vitamin E cream, erythromycin ointment and sticky material are mixed, externally used paste is obtained；
Effective component in the Fluonex, ofloxacin gel, urea and vitamin E cream and erythromycin ointment contains
It measures consistent with the content of the composition.
Preferably, the composition is made of following commercially available finished product: hydroxytetracycline tablet 6g, vitamin B2 piece 35mg, berberine
Piece 30mg, azithromycin capsule 1g, Fluonex 12g, ofloxacin gel 12g, urea and vitamin E cream 8g, kuh-seng
60mg, frutus cnidii 60mg, bodinier velvetplant root 40mg, plain rice tree 60mg, euphorbiae fischerianae 40mg, nauclea officinalis 60mg and erythromycin ointment 15g.
Specifically, urea and vitamin E cream: every gram contains 150 milligrams of urea, vitamin E 10mg；Fluonex 12g,
10 grams contain 2.5mg；Ofloxacin gel 15g, 75mg；Every 30mg of berberine jamaicin；Every 5mg of vitamin B2；Archie
Mycin capsule 0.25g, 1；Erythromycin ointment 1g, 10,000 units, 10mg；Hydroxytetracycline tablet, 0.25g, 250,000 units, 250mg.
Preferably, a kind of composition treated scytitis and promote wound healing, is grouped by the pure material group of following weight
At: terramycin 6000mg, vitamin B2 35mg, berberine 30mg, azithromycin 1000mg, Fluocinonide 3000mg, oxygen fluorine
It is husky star 60mg, urea 1200mg, vitamin E 80mg, kuh-seng 60mg, frutus cnidii 60mg, bodinier velvetplant root 40mg, plain rice tree 60mg, white
Radix euphorbiae lantu 40mg, nauclea officinalis 60mg and erythromycin 150mg.
Three, major function
Suitable for dermatitis, the skin open sore part, epifolliculitis, furuncle, impetigo, psoriasis, acne, eczema, psoriasis, dermatitis,
The skin diseases such as tinea pedis.
Four, usage and dosage
2 times a day (once in the morning and once at night), affected part is smeared.
Five, it avoids
1, quinolone drugs allergy sufferers are disabled.
2, fungi or virus dermatopathy disabling.
Since everyone skin is different, first take a little smearing (rubescent, itch) to this medicine and matrix components allergy
Person's disabling.
Six, points for attention
The more persons of purulent secretion please first reuse this product with physiological saline cleaning affected part.
1 as other anti-infectious agents, extend the undue growth that would potentially result in non-sensitive microorganism using this product, packet
Include fungi.Therefore this product should not be used for a long time.
2, when quinolone drugs systemic administration, even if only once, it is also possible to allergic reaction, certain reaction companions occur
There is cardiovascular collapse, lose one's senses, angioedema (including pharynx, larynx or face's oedema), airway obstruction, expiratory dyspnea, nettle
Rash, itch etc..In case of fash or other anaphylactoid symptoms, should discontinue medication simultaneously referring physician immediately.
3, serious hepatic and kidney function obstacle person is used with caution.
4, this product is please placed on the place that children cannot contact.
Seven, embodiment
Embodiment 1
A kind of composition treated scytitis and promote wound healing, is grouped as by the pure material group of following parts by weight:
5500 parts of terramycin, 30 parts of vitamin B2,20 parts of berberine, 800 parts of azithromycin, 2500 parts of Fluocinonide, urea 1000
Part, 60 parts of vitamin E and 120 parts of erythromycin.
Externally used paste is made in the composition to use.
Embodiment 2
A kind of composition treated scytitis and promote wound healing, the pure material component including following parts by weight: soil
6500 parts of mycin, 45 parts of vitamin B2,40 parts of berberine, 1200 parts of azithromycin, 3500 parts of Fluocinonide, urea 1400
Part, 100 parts of vitamin E, 170 parts of erythromycin and 80 parts of Ofloxacin.
Externally used paste is made in the composition to use.
Embodiment 3
A kind of composition treated scytitis and promote wound healing, the pure material component including following parts by weight: soil
6100 parts of mycin, 40 parts of vitamin B2,30 parts of berberine, 900 parts of azithromycin, 3300 parts of Fluocinonide, urea 1200
Part, 90 parts of vitamin E, 150 parts of erythromycin, 60 parts of Ofloxacin, 70 parts of kuh-seng, 70 parts of frutus cnidii, 40 parts of bodinier velvetplant root, plain rice
60 parts of tree, 45 parts of euphorbiae fischerianae and 60 parts of nauclea officinalis.
Externally used paste is made in the composition to use.
Embodiment 4
A kind of composition treated scytitis and promote wound healing, the pure material component including following parts by weight: soil
5500 parts of mycin, 30 parts of vitamin B2,20 parts of berberine, 800 parts of azithromycin, 2500 parts of Fluocinonide, urea 1200
Part, 60 parts of vitamin E, 120 parts of erythromycin, 40 parts of Ofloxacin, 42 parts of kuh-seng, 42 parts of frutus cnidii, 30 parts of bodinier velvetplant root, plain rice
50 parts of tree, 30 parts of euphorbiae fischerianae and 50 parts of nauclea officinalis.
Externally used paste is made in the composition to use.
Embodiment 5
A kind of composition treated scytitis and promote wound healing, the pure material component including following parts by weight: soil
5500 parts of mycin, 30 parts of vitamin B2,20 parts of berberine, 800 parts of azithromycin, 2500 parts of Fluocinonide, urea 1000
Part, 60 parts of vitamin E, 120 parts of erythromycin, 40 parts of Ofloxacin, 40 parts of kuh-seng, 40 parts of frutus cnidii, 30 parts of bodinier velvetplant root, plain rice
50 parts of tree, 30 parts of euphorbiae fischerianae and 50 parts of nauclea officinalis.
Externally used paste is made in the composition to use.
Embodiment 6
A kind of composition treated scytitis and promote wound healing, the pure material component including following parts by weight: soil
6200 parts of mycin, 40 parts of vitamin B2,35 parts of berberine, 1100 parts of azithromycin, 3200 parts of Fluocinonide, Ofloxacin
70 parts, 1300 parts of urea, 90 parts of vitamin E, 65 parts of kuh-seng, 75 parts of frutus cnidii, 45 parts of bodinier velvetplant root, 65 parts of plain rice tree, euphorbiae fischerianae
45 parts, 65 parts of nauclea officinalis and 160 parts of erythromycin.
Externally used paste is made in the composition to use.
Embodiment 7
A kind of composition treated scytitis and promote wound healing, the pure material component including following parts by weight: soil
5700 parts of mycin, 38 parts of vitamin B2,32 parts of berberine, 950 parts of azithromycin, 2950 parts of Fluocinonide, Ofloxacin 60
Part, 1250 parts of urea, 75 parts of vitamin E, 45 parts of kuh-seng, 45 parts of frutus cnidii, 35 parts of bodinier velvetplant root, 55 parts of plain rice tree, euphorbiae fischerianae 35
Part, 55 parts of nauclea officinalis and 140 parts of erythromycin.
Externally used paste is made in the composition to use.
Embodiment 8
A kind of composition treated scytitis and promote wound healing, the pure material component including following parts by weight: soil
6200 parts of mycin, 40 parts of vitamin B2,35 parts of berberine, 1100 parts of azithromycin, 3000 parts of Fluocinonide, Ofloxacin
55 parts, 1250 parts of urea, 70 parts of vitamin E, 60 parts of kuh-seng, 50 parts of frutus cnidii, 35 parts of bodinier velvetplant root, 65 parts of plain rice tree, euphorbiae fischerianae
35 parts, 55 parts of nauclea officinalis and 150 parts of erythromycin.
Externally used paste is made in the composition to use.
Embodiment 9
A kind of composition treated scytitis and promote wound healing, the pure material component including following parts by weight: soil
6000 parts of mycin, 35 parts of vitamin B2,30 parts of berberine, 1000 parts of azithromycin, 3000 parts of Fluocinonide, Ofloxacin
60 parts, 1200 parts of urea, 80 parts of vitamin E, 60 parts of kuh-seng, 60 parts of frutus cnidii, 40 parts of bodinier velvetplant root, 60 parts of plain rice tree, euphorbiae fischerianae
40 parts, 60 parts of nauclea officinalis and 150 parts of erythromycin.
Externally used paste is made in the composition to use.
Embodiment 10
A kind of composition treated scytitis and promote wound healing, the pure material component including following parts by weight: soil
6400 parts of mycin, 42 parts of vitamin B2,35 parts of berberine, 1100 parts of azithromycin, 3100 parts of Fluocinonide, Ofloxacin
60 parts, 1200 parts of urea, 80 parts of vitamin E, 60 parts of kuh-seng, 60 parts of frutus cnidii, 45 parts of bodinier velvetplant root, 65 parts of plain rice tree, euphorbiae fischerianae
45 parts, 65 parts of nauclea officinalis and 150 parts of erythromycin.
Externally used paste is made in the composition to use.
Embodiment 11
A kind of composition treated scytitis and promote wound healing, the pure material component including following parts by weight: soil
6200 parts of mycin, 40 parts of vitamin B2,40 parts of berberine, 1000 parts of azithromycin, 3200 parts of Fluocinonide, Ofloxacin
60 parts, 1200 parts of urea, 90 parts of vitamin E, 60 parts of kuh-seng, 70 parts of frutus cnidii, 45 parts of bodinier velvetplant root, 60 parts of plain rice tree, euphorbiae fischerianae
40 parts, 60 parts of nauclea officinalis and 160 parts of erythromycin.
Externally used paste is made in the composition to use.
Clinical case
A kind of composition treated scytitis and promote wound healing, be grouped as by the pure material group of following weight: soil is mould
Plain 6000mg, vitamin B2 35mg, berberine 30mg, azithromycin 1000mg, Fluocinonide 3000mg, Ofloxacin
60mg, urea 1200mg, vitamin E 80mg, kuh-seng 60mg, frutus cnidii 60mg, bodinier velvetplant root 40mg, plain rice tree 60mg, euphorbiae fischerianae
40mg, nauclea officinalis 60mg and erythromycin 150mg.
Externally used paste is made in above-mentioned composition, carries out clinical verification below.
1, Zhang: male, 44 years old, illness: seborrheica epifolliculitis medical history 8 years, played red dot and comes to a head, hair follicle is damaged bald on head
Top, by wiping this product, two weeks symptoms of medication disappear.Do not find adverse reaction.
2, Lee: male, 56 years old, illness: epifolliculitis, medical history 3 months, red dot was played in many places on head, by wiping this product, medication
Symptom disappears within two weeks.Do not find adverse reaction.
3, Chen: male, 57 years old, illness: epifolliculitis, medical history 3 months, red dot was played in many places on head, by wiping this product, medication
Symptom disappears within two weeks.Do not find adverse reaction.
4, Xiong: male, 46 years old, illness: epifolliculitis, medical history 2 months, red dot was played in many places on head, by wiping this product, medication
Symptom disappears within one week.Do not find adverse reaction.
5, Jiang: female, 14 years old, illness: acne, medical history 1 year, on head, on the face, play red dot with it, by wiping this product, use
Three weeks days symptoms of medicine disappear.Do not find adverse reaction.
6, Zhang: male, 19 years old, illness: acne medical history 2 months, played red dot on head, by wiping this product, one Zhou Tian of medication
Symptom disappears.Do not find adverse reaction.
7, Lee: male, 68 years old, illness: psoriasis, medical history 32 years, with it, patch on foot, by wiping this product, medication three
All symptoms mitigate.Do not find adverse reaction.
8, Mr. Wang: female, 55 years old, illness: the left foot palm, right hand palm of the hand eczema, medical history 15 years, pain, which is itched, got blister, by wiping
This product, three weeks symptoms of medication disappear.Do not find adverse reaction.
9, Guo: female, 55 years old, illness: right hand palm of the hand eczema, medical history 8 years, pain, which is itched, got blister, by wiping this product, medication
Symptom disappears within one week.Do not find adverse reaction.
10, Hu: female, 14 years old, illness: neck dermatitis, medical history 1 year, by wiping this product, medication three days, symptom disappeared.
Do not find adverse reaction.
11, Zheng: female, 34 years old, illness: neck dermatitis, medical history 3 years, by wiping this product, medication three days, symptom disappeared.
Do not find adverse reaction.
12, Mr. Wang: female, 29 years old, illness: left face temple dermatitis disease, medical history 1 year, by wiping this product, one week disease of medication
Shape disappears.Do not find adverse reaction.
13, Lee: female, 41 years old, illness: foot bifurcation, sole, which are got blister, itched, and medical history 22 years, by wiping this product, medication two
All symptoms disappear, and lower-left cheek psoriasis, medical history 21 years, by wiping this product, two weeks symptoms of medication were obviously improved.Do not find
Adverse reaction.
14, Lee: female, 50 years old, illness: tinea pedis (rotten foot bifurcation), medical history 6 years, foot bifurcation, which is got blister, itched, originally by wiping
Product, three days symptoms of medication disappear.Do not find adverse reaction.
15, white horse with a black mane: male, 46 years old, illness: tinea pedis (rotten foot bifurcation), medical history 25 years, foot bifurcation, sole, which are got blister, itched, by wiping
This product is wiped, one week symptom of medication disappears.Do not find adverse reaction.
16, Jiang: female, 56 years old, illness: tinea pedis (rotten foot bifurcation), medical history 5 years, foot bifurcation, which is got blister, itched, originally by wiping
Product, three days symptoms of medication disappear.Do not find adverse reaction.
17, Cai: female, 32 years old, illness: tinea pedis (rotten foot bifurcation), medical history 8 years, foot bifurcation, which is got blister, itched, originally by wiping
Product, five days symptoms of medication disappear.Do not find adverse reaction.
The present invention is not limited to above-mentioned optional embodiment, anyone can show that other are each under the inspiration of the present invention
The product of kind form.Above-mentioned specific embodiment should not be understood the limitation of pairs of protection scope of the present invention, protection of the invention
Range should be subject to be defined in claims, and specification can be used for interpreting the claims.
Claims (10)
1. a kind of composition treated scytitis and promote wound healing, it is characterised in that: the pure object including following parts by weight
Matter component: 5500-6500 parts of terramycin, 30-45 parts of vitamin B2,20-40 parts of berberine, 800-1200 parts of azithromycin, vinegar
Sour fluocinolone acetonide 2500-3500 parts, 1000-1400 parts of urea, 60-100 parts of vitamin E and 120-170 parts of erythromycin.
2. a kind of composition treated scytitis and promote wound healing according to claim 1, it is characterised in that: including
The pure material component of following parts by weight: 5500-6500 parts of terramycin, 30-45 parts of vitamin B2,20-40 parts of berberine, Ah
It is 800-1200 parts of miramycin, 2500-3500 parts of Fluocinonide, 1000-1400 parts of urea, 60-100 parts of vitamin E, red mould
Plain 120-170 parts and Ofloxacin 40-80 parts.
3. a kind of composition treated scytitis and promote wound healing according to claim 1, it is characterised in that: including
The pure material component of following parts by weight: 5500-6500 parts of terramycin, 30-45 parts of vitamin B2,20-40 parts of berberine, Ah
It is 800-1200 parts of miramycin, 2500-3500 parts of Fluocinonide, 1000-1400 parts of urea, 60-100 parts of vitamin E, red mould
120-170 parts plain, 40-80 parts of Ofloxacin, 40-80 parts of kuh-seng, 40-80 parts of frutus cnidii, 30-50 parts of bodinier velvetplant root, plain rice tree 50-
70 parts, 30-50 parts of euphorbiae fischerianae and 50-70 parts of nauclea officinalis.
4. a kind of composition treated scytitis and promote wound healing according to claim 1, it is characterised in that: including
The pure material component of following parts by weight: 5600-6200 parts of terramycin, 35-40 parts of vitamin B2,25-35 parts of berberine, Ah
900-1100 parts of miramycin, 2800-3200 parts of Fluocinonide, 50-70 parts of Ofloxacin, 1200-1300 parts of urea, vitamin
70-90 parts of E, 45-65 parts of kuh-seng, 45-75 parts of frutus cnidii, 35-45 parts of bodinier velvetplant root, 55-65 parts of plain rice tree, euphorbiae fischerianae 35-45
Part, 55-65 parts of nauclea officinalis and 140-160 parts of erythromycin.
5. a kind of composition treated scytitis and promote wound healing according to claim 1, it is characterised in that: including
The pure material component of following parts by weight: 6200 parts of terramycin, 40 parts of vitamin B2,35 parts of berberine, azithromycin 1100
Part, 3000 parts of Fluocinonide, 55 parts of Ofloxacin, 1250 parts of urea, 70 parts of vitamin E, 60 parts of kuh-seng, 50 parts of frutus cnidii,
35 parts of bodinier velvetplant root, 65 parts of plain rice tree, 35 parts of euphorbiae fischerianae, 55 parts of nauclea officinalis and 150 parts of erythromycin.
6. a kind of composition treated scytitis and promote wound healing according to claim 1, it is characterised in that: including
The pure material component of following parts by weight: 6000 parts of terramycin, 35 parts of vitamin B2,30 parts of berberine, azithromycin 1000
Part, 3000 parts of Fluocinonide, 60 parts of Ofloxacin, 1200 parts of urea, 80 parts of vitamin E, 60 parts of kuh-seng, 60 parts of frutus cnidii,
40 parts of bodinier velvetplant root, 60 parts of plain rice tree, 40 parts of euphorbiae fischerianae, 60 parts of nauclea officinalis and 150 parts of erythromycin.
7. a kind of composition treated scytitis and promote wound healing according to claim 1, it is characterised in that: including
The pure material component of following parts by weight: 6400 parts of terramycin, 42 parts of vitamin B2,35 parts of berberine, azithromycin 1100
Part, 3100 parts of Fluocinonide, 60 parts of Ofloxacin, 1200 parts of urea, 80 parts of vitamin E, 60 parts of kuh-seng, 60 parts of frutus cnidii,
45 parts of bodinier velvetplant root, 65 parts of plain rice tree, 45 parts of euphorbiae fischerianae, 65 parts of nauclea officinalis and 150 parts of erythromycin.
8. a kind of composition treated scytitis and promote wound healing according to claim 1, it is characterised in that: including
The pure material component of following parts by weight: 6200 parts of terramycin, 40 parts of vitamin B2,40 parts of berberine, azithromycin 1000
Part, 3200 parts of Fluocinonide, 60 parts of Ofloxacin, 1200 parts of urea, 90 parts of vitamin E, 60 parts of kuh-seng, 70 parts of frutus cnidii,
45 parts of bodinier velvetplant root, 60 parts of plain rice tree, 40 parts of euphorbiae fischerianae, 60 parts of nauclea officinalis and 160 parts of erythromycin.
9. a kind of composition treated scytitis and promote wound healing according to claim 2, it is characterised in that: described
The dosage form of composition is externally used paste.
10. a kind of preparation method treated scytitis and promote the composition of wound healing, it is characterised in that: comprising steps of
First terramycin powder, berberine powder, vitamin B2 powder are stirred evenly, azithromycin is then uniformly sprinkled into, obtains
To powder materials；
Lightyellow Sophora Root, Common Cnidium Fruit, bodinier velvetplant root's powder, plain rice tree powder, euphorbiae fischerianae powder and nauclea officinalis powder are mixed, obtained
Drug powder material；
Fluonex, ofloxacin gel, powder materials and drug powder material are stirred evenly, sticky material is obtained；
Urea and vitamin E cream, erythromycin ointment and sticky material are mixed, externally used paste is obtained；
Active constituent content in the Fluonex, ofloxacin gel, urea and vitamin E cream and erythromycin ointment with
The content of corresponding ingredient in composition described in claim 3-9 any one is consistent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910786021.3A CN110384744A (en) | 2019-08-23 | 2019-08-23 | A kind of composition and preparation method treated scytitis and promote wound healing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910786021.3A CN110384744A (en) | 2019-08-23 | 2019-08-23 | A kind of composition and preparation method treated scytitis and promote wound healing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110384744A true CN110384744A (en) | 2019-10-29 |
Family
ID=68289429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910786021.3A Pending CN110384744A (en) | 2019-08-23 | 2019-08-23 | A kind of composition and preparation method treated scytitis and promote wound healing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110384744A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101366735A (en) * | 2008-10-08 | 2009-02-18 | 孟华 | Externally used compound wound plaster prescription |
| CN104027467A (en) * | 2014-06-23 | 2014-09-10 | 王诺生 | Anti-inflammatory medicament capable of treating beriberi and preparation method thereof |
| CN104107376A (en) * | 2014-08-14 | 2014-10-22 | 熊振铭 | Composition and preparation method of external anti-inflammatory drug |
| CN104666415A (en) * | 2015-03-25 | 2015-06-03 | 成都汇智远景科技有限公司 | Compound preparation containing oxytetracycline and traditional Chinese medicine extracts |
| CN106389789A (en) * | 2016-11-22 | 2017-02-15 | 郑州仁宏医药科技有限公司 | Western medicine composition for preventing and treating acne and preparation method of western medicine composition |
| CN108478664A (en) * | 2018-05-17 | 2018-09-04 | 肖耀刚 | A kind of compound skin rehabilitation ointment and preparation method thereof |
-
2019
- 2019-08-23 CN CN201910786021.3A patent/CN110384744A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101366735A (en) * | 2008-10-08 | 2009-02-18 | 孟华 | Externally used compound wound plaster prescription |
| CN104027467A (en) * | 2014-06-23 | 2014-09-10 | 王诺生 | Anti-inflammatory medicament capable of treating beriberi and preparation method thereof |
| CN104107376A (en) * | 2014-08-14 | 2014-10-22 | 熊振铭 | Composition and preparation method of external anti-inflammatory drug |
| CN104666415A (en) * | 2015-03-25 | 2015-06-03 | 成都汇智远景科技有限公司 | Compound preparation containing oxytetracycline and traditional Chinese medicine extracts |
| CN106389789A (en) * | 2016-11-22 | 2017-02-15 | 郑州仁宏医药科技有限公司 | Western medicine composition for preventing and treating acne and preparation method of western medicine composition |
| CN108478664A (en) * | 2018-05-17 | 2018-09-04 | 肖耀刚 | A kind of compound skin rehabilitation ointment and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105833279B (en) | External-use medicine composition for treating various wound surfaces of skin and preparation method thereof | |
| CN101417060B (en) | Plaster capable of treating trauma, traumatic injury, alopecia areata and burn and scald | |
| EA032439B1 (en) | Compositions and methods for treating surface wounds | |
| CN102755573A (en) | External use traditional Chinese medicine for treating onychomycosis | |
| CN101919927B (en) | Spray for promoting scald healing | |
| CN107050118A (en) | It is a kind of to treat Chinese medicine patch of caused by wind, cold and wetness evils and preparation method thereof | |
| CN103566071B (en) | Traditional Chinese medicine composition for treating ulcer and preparation method of powder of traditional Chinese medicine composition | |
| EP3369428B1 (en) | External traditional chinese medicine preparation for diminishing inflammation, relieving pain and promoting fast healing, and preparation method therefor | |
| CN103977194A (en) | Application of drug for external use capable of effectively treating wound infection in preparing medicaments for treating diabetic foot | |
| CN110384744A (en) | A kind of composition and preparation method treated scytitis and promote wound healing | |
| CN106237029B (en) | A kind of aloe antibiotic gel and preparation method thereof | |
| CN102274277A (en) | Tuberculosis medicinal liquor | |
| CN103610841A (en) | Method for treating stomatitis of bamboo rats | |
| CN105168360A (en) | Compound plant extract liniment for treating acne and preparation method of compound plant extract liniment | |
| CN101612203B (en) | Traditional Chinese medicine composition used for treating pointed condyloma and application thereof | |
| CN1048173C (en) | Venereal disease curing powder medicine and method for preparing same | |
| CN107375422A (en) | Treatment part catarrh symptom liniment and preparation method thereof | |
| CN108635362A (en) | A kind of pharmaceutical composition for treating diabetes | |
| CN103585330B (en) | A kind of Chinese medicine composition for cutaneous fungal infection and preparation method thereof | |
| CN102274330B (en) | Medicament for treating beriberi | |
| CN115844993A (en) | A Chinese medicinal disinfectant for oral cavity and skin, and its preparation method | |
| US20170319475A1 (en) | Medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, preparation method therefor and use method thereof | |
| CN104825809A (en) | Medicament for treating peripheral facial paralysis | |
| CN104887702A (en) | Chinese medicinal composition for treating skin injury and ulceration and preparation method thereof | |
| CN107693522A (en) | Application of the Ketoconazol/Clobetasol Propionate in the medicine for preparing treatment allergic dermatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191029 |